DHR vs NTRA
Danaher Corporation and Natera, Inc., both Healthcare
Danaher Corporation is the larger company at $125B against $37B. Over the past year NTRA returned +121% against +13% for DHR. The RyuScore puts DHR ahead, 51 against 18 out of 100.
| Figure | DHR | NTRA |
|---|---|---|
| Last close | $220 | $401 |
| Market cap | $125B | $37B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 39.0 | n/a |
| 1-year return | +13% | +121% |
| 5-year return | -21% | +234% |
| RyuScoresector-relative, 1–10 | 51/100 | 18/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Danaher Corporation
Revenue of $6.3B in Q2 2026, net income $870M. Its largest reported line is Diagnostics, 46% of the disclosed total.
Natera, Inc.
Revenue of $753M in Q2 2026, net income null. Its largest reported line is United States, 98% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.